ECMO for COVID-19 patients in Europe and Israel

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F21%3A10421086" target="_blank" >RIV/00216208:11110/21:10421086 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/21:10421086
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=_fT1qogdxZ" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=_fT1qogdxZ</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00134-020-06272-3" target="_blank" >10.1007/s00134-020-06272-3</a>

Result language
angličtina
Original language name
ECMO for COVID-19 patients in Europe and Israel
Original language description
As of October 17th the novel coronavirus (SARS-CoV-2) caused a pandemic disease (coronavirus disease 2019, COVID-19) 40 million people worldwide, with almost one million deaths. Although most patients have an uncomplicated clinical course, the more severe forms of COVID-19 require hospitalization and intensive care unit admission. Conventional high-flow oxygen therapy, non-invasive and/or invasive mechanical ventilation, often in combination with pronepositioning, have all been reported to be effective in the majority of patients. However, in severe cases, life-threatening, refractory hypoxemia may occur. Secondary infections, myocardial disease involvement and a hypercoaguable state with/without pulmonary embolism may also contribute to the complexity of treating these critically ill patients. In such cases rescue therapy may be required.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30223 - Anaesthesiology

Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)